In the canarypox prime/protein boost RV144 trial, the elicitation of five-function T cells expressing CD40L, IL-2, IL-4, IFN-γ, and TNF-α or three-function T cells expressing CD40L, IL-2, and IL-4 correlated with a reduced risk of infection (12). This evidence concerns the gene CD40LG and infection.